tetano
Editor, Senior Moderator
Klin Monbl Augenheilkd
. 2022 Apr;239(4):537-544.
doi: 10.1055/a-1771-5695. Epub 2022 Apr 26.
Six Cases of Retinal Vascular Anomalies after Coronavirus Disease 2019: A Case Series
Georgios N Tsiropoulos[SUP] 1 2 3 [/SUP], Daniela Gallo Castro[SUP] 1 2 [/SUP], Aude Ambresin[SUP] 1 2 4 [/SUP]
Affiliations
Abstract
in English, German
Background: The novel coronavirus disease 2019 (COVID-19) and its rapid spread has resulted in unexplored clinical ophthalmological manifestations. This report aims to describe a series of retinal vascular anomalies diagnosed with the use of fluorescein angiography, following contraction of COVID-19.
History and signs: Symptoms reported by patients were central scotoma (one case), inferior scotoma (one case), and a sensation of mild loss of vision during the COVID-19 follow-up (four cases). Best-corrected visual acuity was preserved in all patients, apart from one, who had a visual acuity of 0.4, decimal scale (6/15, Snellen) in the left eye.
Therapy and outcome: Clinical manifestations included bilateral retinal vasculitis (two cases), branch retinal vein occlusion (one case), branch retinal artery occlusion (one case), hemi-central retinal vein occlusion (one case), and optic disc edema due to central retinal vein occlusion (one case) occurring 0 - 8 months after COVID-19 contraction. Serological testing was performed in every patient to exclude any other recognized cause of retinal vascular occlusion and inflammation and to confirm immunity against the novel coronavirus. None of the patients required any ocular treatment.
Conclusions: Arterial and venous occlusive as well as inflammatory retinal vascular pathologies can occur both during and after the acute phase of COVID-19 as manifestations of ocular long-term effects of COVID-19 and should be included in the differential diagnosis of retinal occlusive pathologies. This case series suggests that careful investigations, including fundoscopy and fluorescein angiography, should be required in patients with visual complaints, both in the acute and long-term follow-up of COVID-19.
. 2022 Apr;239(4):537-544.
doi: 10.1055/a-1771-5695. Epub 2022 Apr 26.
Six Cases of Retinal Vascular Anomalies after Coronavirus Disease 2019: A Case Series
Georgios N Tsiropoulos[SUP] 1 2 3 [/SUP], Daniela Gallo Castro[SUP] 1 2 [/SUP], Aude Ambresin[SUP] 1 2 4 [/SUP]
Affiliations
- PMID: 35472801
- DOI: 10.1055/a-1771-5695
Abstract
in English, German
Background: The novel coronavirus disease 2019 (COVID-19) and its rapid spread has resulted in unexplored clinical ophthalmological manifestations. This report aims to describe a series of retinal vascular anomalies diagnosed with the use of fluorescein angiography, following contraction of COVID-19.
History and signs: Symptoms reported by patients were central scotoma (one case), inferior scotoma (one case), and a sensation of mild loss of vision during the COVID-19 follow-up (four cases). Best-corrected visual acuity was preserved in all patients, apart from one, who had a visual acuity of 0.4, decimal scale (6/15, Snellen) in the left eye.
Therapy and outcome: Clinical manifestations included bilateral retinal vasculitis (two cases), branch retinal vein occlusion (one case), branch retinal artery occlusion (one case), hemi-central retinal vein occlusion (one case), and optic disc edema due to central retinal vein occlusion (one case) occurring 0 - 8 months after COVID-19 contraction. Serological testing was performed in every patient to exclude any other recognized cause of retinal vascular occlusion and inflammation and to confirm immunity against the novel coronavirus. None of the patients required any ocular treatment.
Conclusions: Arterial and venous occlusive as well as inflammatory retinal vascular pathologies can occur both during and after the acute phase of COVID-19 as manifestations of ocular long-term effects of COVID-19 and should be included in the differential diagnosis of retinal occlusive pathologies. This case series suggests that careful investigations, including fundoscopy and fluorescein angiography, should be required in patients with visual complaints, both in the acute and long-term follow-up of COVID-19.